DNAG Stock Overview
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
DNAPrint Genomics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -99.80% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| DNAG | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 1.2% |
| 1Y | 0% | 0.7% | 24.9% |
Return vs Industry: DNAG underperformed the US Biotechs industry which returned 1.1% over the past year.
Return vs Market: DNAG underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| DNAG volatility | |
|---|---|
| DNAG Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DNAG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DNAG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | n/a | n/a |
DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients.
DNAPrint Genomics, Inc. Fundamentals Summary
| DNAG fundamental statistics | |
|---|---|
| Market cap | US$644.00 |
| Earnings (TTM) | -US$4.55m |
| Revenue (TTM) | US$1.93m |
0.0x
P/S Ratio0.0x
P/E RatioIs DNAG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNAG income statement (TTM) | |
|---|---|
| Revenue | US$1.93m |
| Cost of Revenue | US$1.48m |
| Gross Profit | US$446.37k |
| Other Expenses | US$5.00m |
| Earnings | -US$4.55m |
Last Reported Earnings
Sep 30, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DNAG perform over the long term?
See historical performance and comparison